Independent. Strategic. Authoritative.
Edited since 2008, PHARMAnetwork magazine is a quarterly international business publication, covering every aspect of the pharmaceutical value chain at the intersection between the pharmaceutical and outsourcing industries.
PHARMAnetwork magazine's independent editorial line offers a perspective and a synthesis of the flow of international news with the aim of bringing the most important information to decision-makers in the pharmaceutical industry.
PHARMAnetwork celebrates the cardinal values of journalism, to make the right checks, to gather evidence, and provide our readers with information of the highest standard in order to make our news reliable and ensure that our readers can trust us
Our content is designed for professionals across pharmaceutical companies, biotechs and CDMOs seeking structured
analysis rather than promotional messaging.
Our editorial scope
PHARMAnetwork magazine covers the full spectrum of topics shaping pharmaceutical contract manufacturing, including:
- Market intelligence and capacity dynamics;
- Corporate positioning and organizational models;
- Investments, Capex and industrial expansion projects;
- Finance and M&A activity across CDMOs;
- Regulatory frameworks and quality expectations;
- Legal and compliance issues impacting manufacturing operations.
Articles explore both operational and strategic dimensions of contract manufacturing and outsourcing services to bio / pharmaceutical industries
Type of content
Our editorial formats include:
- In-depth market analyses;
- Industry perspectives;
- Investment and manufacturing site reviews;
- Executive interviews;
- Regulatory and compliance briefings.
Content is developed to provide context, structure and long-term perspective, supporting informed decision-making.
Geographic coverage
PHARMAnetwork reports on CDMO market dynamics across Europe and the United States, with regular analysis of key Asian
manufacturing hubs. While print distribution is primarily European and North American, digital readership extends globally.
Audience
Our readership includes:
- In-depth market analyses;
- CDMO executives and operational leaders;
- Pharmaceutical manufacturing and supply chain teams;
- Business development and strategy professionals;
- Investors and advisors active in life sciences manufacturing.
PHARMAnetwork’s editorial line reflects a commitment to industrial relevance, analytical depth and professional readership.
Read our last issue
